BHP Billiton Secure Bauxite Supply from Guinea

BHP Billiton today announced the acquisition of a 33.3 per cent interest in Global Alumina’s Sangaredi Refinery Project in Guinea, West Africa, for a consideration of US$140 million.

The project comprises the design, construction and operation of a 3Mtpa alumina refinery, 9Mtpa bauxite mine, and associated infrastructure. A mining concession covering 690km² has been secured and a mineral resource of 233 million tonnes bauxite (@ 39% Available Alumina and 1% Reactive Silica) has been reported. This is considered sufficient to support the development, but further exploration work is underway to increase the resource size.

The proposed refinery site is approximately 100km inland from Kamsar and has the benefit of access to existing rail infrastructure linking it to the Port of Kamsar, where dedicated facilities are already under construction.

"This project provides the Joint Venture partners with access to a long life, low cost, world class resource base and represents an excellent opportunity for BHP Billiton to continue to grow its business in a value accretive manner" commented Graeme Hunt, President Aluminium for BHP Billiton.

"In view of BHP Billiton’s other exploration interests in Guinea, this project also offers us valuable experience of operating in this first tier minerals province," he added.

As part of the agreement, BHP Billiton will appoint the Chief Executive Officer and Chief Financial Officer of the Joint Venture Company (JVC) and will enter into a services agreement with the JVC for the development, construction and operation of the project, which will be operated in accordance with BHP Billiton standards.

Global Alumina will now hold a 33.3 per cent equity interest in the Sangaredi Refinery Project, Dubai Aluminium Company Limited a 25 per cent interest and Mubadala Development Company PJSC 8.3 per cent.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.